ASP
OMED

Adams Street Partners’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Adams Street Partners’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-490,707
Closed -$2.01M – 17
2017
Q4 		$2.01M Sell
490,707
-982,354
-67% -$4.27M 0.48% 8
2017
Q3 		$6.66M Sell
1,473,061
-366,669
-20% -$1.49M 1.7% 5
2017
Q2 		$6.13M Hold
1,839,730
– – 1.44% 6
2017
Q1 		$16.9M Hold
1,839,730
– – 4.17% 4
2016
Q4 		$14.2M Hold
1,839,730
– – 3.9% 5
2016
Q3 		$19.6M Hold
1,839,730
– – 3.7% 5
2016
Q2 		$22.6M Hold
1,839,730
– – 3.71% 5
2016
Q1 		$18.6M Hold
1,839,730
– – 3.39% 6
2015
Q4 		$41.5M Buy
1,839,730
+176,080
+11% +$3.61M 7.46% 4
2015
Q3 		$27.6M Hold
1,663,650
– – 5.86% 3
2015
Q2 		$37.4M Hold
1,663,650
– – 5.63% 4
2015
Q1 		$42.9M Buy
+1,663,650
New +$42.2M 6.84% 3

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return